In 33 heavily pretreated NSCLC EGFR wild-type (EGFRwt) patients the combination of AFM24 and atezolizumab shows an overall response rate (ORR) of ...

Cancer is one of the most formidable health challenges of our time, affecting nearly half of us during our lives. While treatments have significantly improved in recent decades, the biggest challenge ...

The study characterizes the lung cancer tumor microenvironment, linking cellular compositions to immunotherapy resistance and ...

A new study has revealed that different types of cancer leave distinct molecular “fingerprints” detectable in their early ...

From life-saving medicine to gratitude for caregivers and a surprise romance, these stories remind us of the power of human connection.

National Institute of Health (NIH) scientists have made a significant breakthrough in understanding how "bad" cholesterol, known as low-density lipoprotein-cholesterol or LDL-C, builds up in the body.

The Ohio House passed a bill making asbestos lawsuits harder to win, over objections from veterans and firefighters. It now ...

Different types of cancer have unique molecular "fingerprints" that can be picked up using handheld scanners in just a few ...

The breakthrough designation for Daiichi Sankyo comes after early pooled results from two ongoing trials finding the drug was well tolerated.

Lung cancer, encompassing both small cell and non-small cell types and affecting men and women almost equally, stands as the ...

Aging induces iron deficiency, reducing stem cell function and tumor growth while enhancing ferroptosis resistance, revealing ...

Each state requires people to have lived there for at least 12 months to access voluntary assisted dying. Linda was the first ...